Back to the main directory
EarningsReview / Equity
- Maisons du Monde SA - A degraded Q2 but in line with our expectations. by MidCap Partners
- INVEST SECURITIES - ARGAN : Poursuite de la croissance sur fond de stabilisation des valeurs - NEUTRE, OC 80,8€ vs 75,2€ by Invest Securities
- INVEST SECURITIES - CAPGEMINI : Reprise confirmée, mais plus lente que prévu 6 ACHAT, OC 240€ vs 248€ by Invest Securities
- discoverIE Group (DSCV LN) by HSBC
- Record - Strong performance fees by Edison Investment Research
- Problems Under the Sun - IRA Repeal, Trade, Demand, Etc. A Teach-In by BNP Paribas Exane
- Bangladesh Update: 4 Week Delay by BNP Paribas Exane
- Non material data changes by BNP Paribas Exane
- Suntec REIT (SUN SP) by HSBC
- 2Q24: Setting up for a stronger 2H by BNP Paribas Exane
- Unicaja in talks with Fiserv - Clover coming soon to Spain? by BNP Paribas Exane
- Still legs left in pipeline recovery story by BNP Paribas Exane
- Even better than expected by BNP Paribas Exane
- Improving operating momentum by BNP Paribas Exane
- Q2 results come with less visibility on margins by BNP Paribas Exane
- Transformation plan ongoing by BNP Paribas Exane
- Non material data changes by BNP Paribas Exane
- All-round beat; festive season to affirm demand recovery by BNP Paribas Exane
- Non material data changes by BNP Paribas Exane
- Q2'24: Hauling beats and cash, keep O/P by BNP Paribas Exane
- NTPC (NTPC IN) by HSBC
- On to the Strategy Day by BNP Paribas Exane
- Slight miss in Q2; Challenging H2 by BNP Paribas Exane
- Nokia (Hold, TP: EUR3.80) - Weak markets casting a shadow by DnB Markets
- Transocean (Hold, TP: USD6.00) - Leader at a premium by DnB Markets
- PHILIPS: RDOS. 2T’24 (ANÁLISIS BANCO SABADELL) by Sabadell
- INVEST SECURITIES - CARMILA : Bon opérationnel et stabilisation des valeurs comme attendu 6 ACHAT, OC 19,9€ vs 19,0€ by Invest Securities
- INVEST SECURITIES - MERCIALYS : Stabilisation des valeurs et opérationnel satisfaisant - ACHAT, OC 12,9€ vs 12,1€ by Invest Securities
- Immix Biopharma - US$8m grant to advance novel CAR-T treatment by Edison Investment Research
- Westports Holdings Berhad (WPRTS MK) by HSBC
- Kering - ANOTHER CUT TO ESTIMATES IN A STILL WEAK SECTOR CONTEXT by Equita Sim
- Curve steepener by BNP Paribas Exane
- Modest revisions, valuation anomaly persists by BNP Paribas Exane
- Align Technology Inc (ALGN US) by HSBC
- Metlen Energy & Metals - Strengthening operating margin in H1 by Edison Investment Research
- EBRO FOODS: RDOS. 2T’24 (ANÁLISIS BANCO SABADELL) by Sabadell
- EBRO FOODS: 2Q’24 RESULTS (ANÁLISIS BANCO SABADELL) by Sabadell
- Capitaland India Trust (CLINT SP) by HSBC
- HgT - Preliminary H124 NAV total return of 5.6% by Edison Investment Research
- Colgate-Palmolive India (CLGT IN) by HSBC
- Q2 prelims: Strong quarterly results plus guidance increase by BNP Paribas Exane
- Good H1, consensus upgrades likely for H2 by BNP Paribas Exane
- Kinsus (3189 TT) by HSBC
- H124 results and 15 questions for management by BNP Paribas Exane
- Power Grid Corp Of India (PWGR IN) by HSBC
- In the Flow by BNP Paribas Exane
- Typical beat & raise impacted by issue in Skeletal segment by BNP Paribas Exane
- Hexagon (Buy, TP: SEK135.00) - Ex-growth equal discount valuation by DnB Markets
- Scorpio Tankers (Buy, TP: USD96.00) - Focus shifting to capital returns by DnB Markets
- PhotoCure (Buy, TP: NOK87.00) - Important long-term deal by DnB Markets